In this study, we confirmed the results by experiments on CRC cells and found that the YAP1 inhibitor verteporfin decreased the expression of PD-L1, CXCL5, COX-2, IL-6, and CSF1-3 (Figure 8). This evidence concerns the gene CSF1 and colorectal carcinoma.